There are impressive levels of strength and decent buy setups in small and mid-cap semiconductor names, plus a rebound in Chinese stocks.
Ant Group's political rehabilitation appears complete, with a holding company restructuring that means Ma no longer dominates voting power.
Is Ant's two-year punishment by the Chinese government coming to an end? It certainly seems so.
If the reopening was that bullish shouldn't buyers be more aggressive?
Entering 2023, we can feel inflation easing and are watching for long-term gain from the removal of zero-Covid in China, even if it results in short-term pain.
Private data will need to give us a picture of what's going on in China, where a bleak winter awaits.
The Bank of Japan shocked world markets with a tweak of its super-easy monetary policy, pushing yen gains that are likely to be sustained in 2023.
Many businesses in China report difficulties due to staffing shortages, but the official tallies of infections and deaths don't reflect that situation.
The SEC's accounting arm said it's confident it has secured "complete access" to the books of U.S.-listed Chinese companies.
India's largest-ever public offering at the time of its listing, Paytm has seen its share price perform horribly. Will this vote of confidence turn things around?